Suchergebnisse - "Sanz, Miguel A"

PubPharm (425)

81

Correction to: A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia

enthalten in: Annals of hematology | 2018

von Martínez-Cuadrón, D. | Boluda, B. | Martínez, P. | +18

82

Correction to: A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia

enthalten in: Annals of hematology | 2018

von Martínez-Cuadrón, D. | Boluda, B. | Martínez, P. | +18

83

Correction to: A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia

enthalten in: Annals of hematology | 2018

von Martínez-Cuadrón, D. | Boluda, B. | Martínez, P. | +18

84

A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia

enthalten in: Annals of hematology | 2018

von Martínez-Cuadrón, D. | Boluda, B. | Martínez, P. | +18

85

A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia

enthalten in: Annals of hematology | 2018

von Martínez-Cuadrón, D. | Boluda, B. | Martínez, P. | +18

86

A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia

enthalten in: Annals of hematology | 2018

von Martínez-Cuadrón, D. | Boluda, B. | Martínez, P. | +18

87

The Initiation Factors eIF2, eIF2A, eIF2D, eIF4A, and eIF4G Are Not Involved in Translation Driven by Hepatitis C Virus IRES in Human Cells

enthalten in: Frontiers in microbiology | 2018

von González-Almela, E. | Williams, H. | Sanz, M. | +1

88

Acute Promyelocytic Leukemia : A Clinical Guide

Erschienen: Cham, Springer International Publishing, 2018

SpringerLink, Bücher

von Abla, O. | Lo Coco, F. | Sanz, M.

89

Acute Promyelocytic Leukemia : A Clinical Guide

Erschienen: Cham, Springer, 2018

von Abla, O. | Lo Coco, F. | Sanz, M.

90

Allogeneic hematopoietic cell transplantation in an adult patient with Glanzmann thrombasthenia

enthalten in: Clinical case reports | 2017

von Cid, A. | Montesinos, P. | Sánchez-Guiu, I. | +13